HALO logo
halo search icon
Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc.
PHAT · NAS

Phathom Pharmaceuticals, Inc.

US$11.87

Price Arrow0.47 (4.12%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapEMA 125 BreakdownHALO AllHALO Consensus ValueHammer BullishHammer Bullish (Realtime)+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Phathom Pharmaceuticals, Inc. Overview

PHAT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About PHAT

icon

Telephone

1.877.742.8466

icon

Address

Suite 102, 100 Campus Drive, Florham Park, NJ 07932

Description

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

PHAT Price Chart

Key Stats

Market Cap

US$909.22M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.69 - 18.31

Trade Value (12mth)

US$4,030,153.00

1 week

-3.96%

1 month

-11.49%

YTD

-27.43%

1 year

192.31%

All time high

64.54

Key Fundamentals

EPS 3 yr Growth

-40.00%

EBITDA Margin

-91.00%

Operating Cashflow

-$167m

Free Cash Flow Return

-82.50%

ROIC

-109.50%

Interest Coverage

-2.30

Quick Ratio

1.70

Other Data

Shares Outstanding (Fully Diluted)

82m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

PHAT Announcements

Latest Announcements

DateAnnouncements
30 April 26
30 April 26
30 April 26
30 April 26
26 February 26

PHAT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-3.93-5.29-3.03locklocklock
EPS (Fully Diluted)
$locklocklocklock-3.93-5.29-3.03locklocklock
Growth
%locklocklocklock22.2-34.642.7locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Phathom Pharmaceuticals, Inc. (PHAT:NAS)?
Halo FAQ
The current share price of Phathom Pharmaceuticals, Inc. (PHAT:NAS) is USD$11.87.
What is the 52-week high share price for Phathom Pharmaceuticals, Inc. (PHAT:NAS)?
Halo FAQ
The 52-week high share price for Phathom Pharmaceuticals, Inc. (PHAT:NAS) is USD$18.31.
What is the 52-week low share price for Phathom Pharmaceuticals, Inc. (PHAT:NAS)?
Halo FAQ
The 52-week low share price for Phathom Pharmaceuticals, Inc. (PHAT:NAS) is USD$3.69.
What is the dividend yield for Phathom Pharmaceuticals, Inc. (PHAT:NAS)?
Halo FAQ
Phathom Pharmaceuticals, Inc. (PHAT:NAS) does not pay a dividend.
What was Phathom Pharmaceuticals, Inc. (PHAT:NAS) last dividend payment?
Halo FAQ
Phathom Pharmaceuticals, Inc. (PHAT:NAS) does not pay a dividend.
What is the franking level for Phathom Pharmaceuticals, Inc. (PHAT:NAS)?
Halo FAQ
Phathom Pharmaceuticals, Inc. (PHAT:NAS) has a franking level of 0.00%.
In which sector is Phathom Pharmaceuticals, Inc. (PHAT:NAS) classified?
Halo FAQ
Phathom Pharmaceuticals, Inc. (PHAT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.